Medical aid in dying bill discussed at legislature, powerful testimony presented in Las Vegas
LAS VEGAS (KLAS) — The Nevada Legislature considered a bill Wednesday that would allow doctors to prescribe a pill to help a terminally ill person end their own life.
Assembly Bill 346, sponsored by Democratic Assem. Joe Dalia and Republican Assem. Danielle Gallant would make it legal for a terminally ill patient to request medication to end their own life under certain circumstances.
This follows a similar bill passed through the legislature in 2023 that Republican Governor Joe Lombardo later vetoed.
Patient must be at least 18 years old.
Patient has been diagnosed with a terminal condition by at least two practitioners.
Patient has made an informed and voluntary decision to end his or her own life.
Patient is mentally capable of making such a decision.
Patient is not requesting the medication because of coercion, deception or undue influence.
'I believe the time is now for us to fix this,' Assemblymember Dalia said in his proposal. 'And to allow terminally ill patients to choose their own ending.'
Many for and against the proposal provided testimony in Carson City and Las Vegas.
'This legislation empowers terminally ill people to preserve their dignity and autonomy,' Tia Smith, attorney for ACLU Nevada, said.
Those behind it believe it gives people who are dying the power to choose and stops suffering.
Death doula Melissa Chanselle-Hary shared her experience, speaking to lawmakers in Carson City.
'For those in favor,' Chanselle-Hary said. 'It is because they have lived through or are currently living through an excruciating experience.'
Those against the legislation said it could go against a doctor's Hippocratic oath to administer this kind of medication. Many said they also worry someone could opt for it before their health ultimately improves.
Christiane Mersch explained her stance to 8 News Now after Wednesday's hearing.
'It's not going to be the solution for our patients,' Mersch said. 'What we do need is more support for hospice, medical care.'
There were passionate pleas from both sides in this latest motion for change.
Medical aid in dying is currently legal in ten states and the District of Columbia.
To view the entire committee discussion, click HERE.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
3 hours ago
- Boston Globe
‘People inside Moderna are afraid': As the anti-vaccine climate intensifies, a big local firm has much to lose
Since then, the veteran pharmaceutical executive has applied for about 40 biopharma jobs in Massachusetts. He has gotten only half a dozen interviews and no job offers. Advertisement 'Am I worried? Yes,' said the 64-year-old Somerville resident. 'I think it's entirely possible that I might not land another job.' Morrow's concerns are hardly unfounded. The recent downturn in biotech has Moderna vaulted to the forefront of biotech during the pandemic, becoming a major pillar of the region's economy, but Health and Human Services Secretary Robert F. Kennedy Jr.'s skepticism of vaccines, and mRNA in particular, has cost the company dearly. Advertisement Late last month, the On Monday, The move marked a reversal of what he had promised a key Republican senator during his confirmation hearings, when Kennedy had pledged to maintain the panel. Health Secretary Robert F. Kennedy Jr. during a swearing-in ceremony in the Oval Office on April 18. ERIC LEE/NYT Morrow, who has worked in the pharma industry for about 30 years, including 17 years at GlaxoSmithKline, said anti-vaccine activists have been 'remarkably effective' at distorting the truth about cutting-edge science, including how safe and effective mRNA shots are. 'It makes it harder for anyone who wants to do science to get a job,' he said. Morrow said he was let go in a third round of layoffs in 2024 and estimated that at least 100 Moderna employees lost jobs in Massachusetts last year. Those layoffs were never publicly disclosed, he said. Moderna acknowledged laying off about 50 digital employees in February this year, but has not disclosed layoffs in other departments. A Moderna spokesperson, Christopher Ridley, said the company had no comment about layoffs. Even before President Trump took office, Massachusetts' biopharma hub had been in a prolonged slump because of high interest rates, investors pulling back from risky biotech stocks, and a steep decline in private financing. Advertisement For the first time in more thana decade, total employment in the state's life sciences sector stayed flat in 2024, according to a report by the Massachusetts Biotechnology Education Foundation. The workforce had 143,142 employees last year, an increase of only 0.02 percent over 2023, the report said. From 2013 to 2023, industry jobs grew at an average annual rate of 6.7 percent. Sunny Schwartz, chief executive of the foundation, said massive hiring during the pandemic made a 'correction' almost inevitable. The uncertainty created by the presidential election likely contributed to the stagnant growth. 'The life sciences industry, like any industry, is conservative in their hiring and probably wanted to see what would happen,' she said. At least 60 drug companies in Massachusetts made layoffs or closed in the past 12 months, according to Dan Gold, president of Fairway Consulting Group, a life sciences recruiting firm. He estimated that at least 1,000 employees lost their jobs. Biogen, the homegrown biotech that has been a mainstay of Kendall Square, has made several rounds of Biogen's headquarters in Cambridge. John Tlumacki/Globe Staff 'I've been a biotech entrepreneur for 20 years, and I haven't seen a worse downturn,' said David Lucchino, the former chief executive of Frequency Therapeutics, now defunct, and a former chair of the Massachusetts Biotechnology Council, an industry trade group. Advertisement Robert Langer, the prolific inventor and biomedical engineering professor at MIT who helped co-found Frequency and Moderna, agreed. He said the slump is the longest-lasting he has seen in his half-century as an entrepreneur. The impact on the real estate market has been devastating. The biotech cluster based in Greater Boston is grappling with a record 16.3 million square feet of unleased lab space, according to the real estate firm Colliers. Nearly Despite some noteworthy successes this year — including Nothing has been whipsawed more than Moderna, which grew to become the second-biggest biopharma employer in Massachusetts, behind Takeda. Before the pandemic, the company had no approved products. Then, in 2020, it won billions of dollars in federal contracts to rapidly develop a COVID vaccine as part of Operation Warp Speed during Trump's first administration. Moderna's mRNA vaccine was cleared by the FDA in December 2020. The Advertisement 'It's been a long fall from grace,' said Tyler Van Buren, an analyst at TD Cowen, a financial research and advisory firm. To a large extent, he said, Moderna was 'a victim of circumstance.' The company was built 'to save the world, and the world stopped wanting or needing the COVID vaccine,' Van Buren added. He also faults Moderna for failing to diversify its pipeline by developing other scientific platforms besides mRNA, in contrast to the German biotech BioNTech, which partnered with Pfizer on its COVID vaccine. Although the first Trump administration touted Moderna's COVID shot as a remarkable achievement, Health Secretary Kennedy has said certain vaccines for respiratory diseases, including mRNA shots, have 'never worked.' Reached for comment by the Globe, Moderna said Monday that 'mRNA vaccines funded by Operation Warp Speed were essential to ending the COVID-19 pandemic, preventing an estimated 20 million deaths worldwide, including more than 1 million in the United States. The efficacy and safety profile has been confirmed in over a billion people worldwide.' A view of Moderna's Cambridge headquarters. David L. Ryan/Globe Staff Moderna's share price, which peaked at $484 in 2021, is now trading at about $28, roughly what it was before the pandemic. Its workforce at the end of last year, however, was roughly seven times what it was before the pandemic, with 5,800 employees. Moderna's chief executive, Stéphane Bancel, said in January that the company will reduce its costs by $1 billion this year. Van Buren said there is 'zero doubt in my mind' that the company will make hundreds of layoffs in the next two years, in part because the political climate toward mRNA vaccines has become so hostile. Advertisement Another scientist at Moderna who was laid off in December said 'multiple hundreds of workers' were let go in Massachusetts since the third quarter of 2023, and that the company has never made it public. 'It's been really opaque,' said the former employee, who insisted on anonymity because he didn't want to jeopardize his severance package. 'I think what [Moderna's leaders] owe to Massachusetts is to be transparent about what they are doing." A third employee, Nathan Devaud, 24, said he was laid off from a job in technical development at Moderna's Norwood facility in late February along with about 80 other people. He had worked at the company for six months while a co-op at Northeastern University, where he earned a bachelor's degree in chemical engineering and biochemistry a year ago, and then for nine months as a full-time employee. He said he has applied for about 25 jobs but hasn't been able to get an interview. 'It's hard to find a job on LinkedIn that doesn't have over a hundred applicants,' he said. Morrow, for his part, said he talks to his former Moderna colleagues, and they're worried. 'People inside Moderna are afraid right now,' he said. 'They're afraid of what's going to come next. To be laid off in this environment makes it that much more stressful.' Jonathan Saltzman can be reached at
Yahoo
3 hours ago
- Yahoo
Advocates: Medicaid ‘not a luxury,' lawmakers need plan for fallout
GAINES TOWNSHIP, Mich. (WOOD) — After the U.S. House approved the 'One Big Beautiful Bill Act,' which includes Medicaid reforms, advocates in West Michigan are sharing their concerns. 'Medicaid is not a luxury, it's a lifeline,' Vanessa Greene, CEO of the Grand Rapids African American Health Institute, said at a Thursday afternoon press conference. 'It is the difference between stability and crisis for over 75 million Americans, including working families, children people with disabilities, our veterans and people living with chronic conditions.' The press conference held at the Disability Advocates of Kent County included nonprofits, health care providers and residents who opposed the proposed changes to Medicaid. They include cuts to Medicaid to target waste and fraud, Republican lawmakers say, as well as enhanced work requirements. House passes Trump's 'big, beautiful bill' in marathon overnight session 'We often say that health is wealth, and health is wealth because when you're healthy, you can thrive. You can work, you can go to school and you can take care of your family members,' Megan Erskine, CEO of Catherine's Health Center, said. Erskine said 60% of Catherine's Health Center patients are on Medicaid. They receive dental services, medical services and mental health services at the center. 'Thirty percent of people on Medicaid in Kent County are your friends, your neighbors and your family members. They are not fraud, abuse and waste,' she said. Scott Becker, who has osteogenesis imperfecta, a brittle bone disease, says Medicaid helps to pay for his medication and keeps him independent, and these changes could one day leave him homeless. 'If it weren't for Medicaid, I don't know where I would be living. Medication has just skyrocketed pricewise, and most of the medications that I take are $300, $400 (or) $1,000 for one prescription. That's just insane to me that other countries pay a tenth of what we do here in the states,' he said. President Trump announces plan to cut prescription drug costs 'No one should be denied care because they are too sick, too poor or too different to matter,' Greene said. Jennie Knight has worked in health care most of her life, and she is a mom of a Medicaid recipient. She says that the system is broken and needs to be fixed. '(Lawmakers should) talk to the people who actually have the expertise in how it could be fixed and managed to be better. We're always looking at cost, we're always looking at efficiencies, but this is not it. When you cut stuff like this so drastically without having plans in place for the fallout of it, it's disastrous,' she said. The Medicaid reforms are part of a bill that would also eliminate taxes on tips and overtime work, bring cuts to the SNAP program and raise the debt ceiling by $4 trillion. The House approved the package in a 215-214 early Thursday morning vote. It is now off to the Senate. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
3 hours ago
- Yahoo
RFK Jr fires entire US vaccine committee
Robert F Kennedy Jr has dismissed all current members of a key federal vaccine advisory panel, accusing them of conflicts of interest. The removal of all 17 experts of the advisory committee on immunisation practices was revealed in a Wall Street Journal op-ed and an official press release. Mr Kennedy, the US health secretary, who has spent two decades amplifying vaccine misinformation, cast the move as essential to restoring public trust, claiming the committee had been compromised by financial ties to pharmaceutical companies. 'Today we are prioritising the restoration of public trust above any specific pro or anti-vaccine agenda,' he said in a statement from the Department of Health and Human Services. 'The public must know that unbiased science – evaluated through a transparent process and insulated from conflicts of interest – guides the recommendations of our health agencies.' In his op-ed, Mr Kennedy claimed the panel was 'plagued with persistent conflicts of interest' and had become 'little more than a rubber stamp for any vaccine'. He added that new members were being considered to replace those ousted, all of whom were appointed under Joe Biden, the former president. Committee members are chosen for their recognised expertise and are required to disclose potential conflicts of interest. 'RFK Jr and the Trump administration are taking a wrecking ball to the programs that keep Americans safe and healthy,' Chuck Schumer, the Senate Democratic leader, said in response. Republican Senator Bill Cassidy, a medical doctor who expressed concern about Mr Kennedy's track record during his Senate nomination but ultimately voted in his favour, wrote on X: 'Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion. 'I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case.' The decision drew sharp criticism from Paul Offit, a paediatrician and leading expert on virology and immunology, who served on the panel from 1998 to 2003. 'He believes that anybody who speaks well of vaccines, or recommends vaccines, must be deeply in the pocket of industry,' Mr Offit told AFP. 'He's fixing a problem that doesn't exist.' 'We are witnessing an escalating effort by the administration to silence independent medical expertise and stoke distrust in life-saving vaccines,' added Susan Kressly, president of the American Academy of Paediatrics, in a statement. Once a celebrated environmental lawyer, Kennedy pivoted to public health from the mid-2000s, chairing a non-profit that discouraged routine childhood immunisations and amplified false claims, including the long-debunked theory that the Measles, Mumps and Rubella (MMR) vaccine causes autism. Since taking office, he has curtailed access to Covid shots and continued to raise fears around the MMR vaccine even as the US faces its worst measles outbreak in years, with three reported deaths and more than 1,100 confirmed cases. Experts have warned that the true case count is likely to be far higher. 'How can this country have confidence that the people RFK Jr. wants on the advisory committee on immunisation practices are people we can trust?' asked Mr Offit. He recalled that during Donald Trump's first term as US president, several states formed independent vaccine advisory panels after the administration pressured federal health agencies to prematurely approve Covid vaccines ahead of the 2020 election. He warned that kind of fragmentation could happen again. The advisory committee on immunisation practices is scheduled to hold its next meeting at the headquarters of the Centers for Disease Control and Prevention in Atlanta from June 25 to June 27. Vaccines for anthrax, Covid, human papillomavirus, influenza, Lyme disease, respiratory syncytial virus, and more are on the agenda. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
